Cargando…

Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro)

Detalles Bibliográficos
Autores principales: Mengist, Hylemariam Mihiretie, Fan, Xiaojiao, Jin, Tengchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210460/
https://www.ncbi.nlm.nih.gov/pubmed/32388537
http://dx.doi.org/10.1038/s41392-020-0178-y
_version_ 1783531276593004544
author Mengist, Hylemariam Mihiretie
Fan, Xiaojiao
Jin, Tengchuan
author_facet Mengist, Hylemariam Mihiretie
Fan, Xiaojiao
Jin, Tengchuan
author_sort Mengist, Hylemariam Mihiretie
collection PubMed
description
format Online
Article
Text
id pubmed-7210460
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72104602020-05-11 Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro) Mengist, Hylemariam Mihiretie Fan, Xiaojiao Jin, Tengchuan Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2020-05-09 /pmc/articles/PMC7210460/ /pubmed/32388537 http://dx.doi.org/10.1038/s41392-020-0178-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Highlight
Mengist, Hylemariam Mihiretie
Fan, Xiaojiao
Jin, Tengchuan
Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro)
title Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro)
title_full Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro)
title_fullStr Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro)
title_full_unstemmed Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro)
title_short Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro)
title_sort designing of improved drugs for covid-19: crystal structure of sars-cov-2 main protease m(pro)
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210460/
https://www.ncbi.nlm.nih.gov/pubmed/32388537
http://dx.doi.org/10.1038/s41392-020-0178-y
work_keys_str_mv AT mengisthylemariammihiretie designingofimproveddrugsforcovid19crystalstructureofsarscov2mainproteasempro
AT fanxiaojiao designingofimproveddrugsforcovid19crystalstructureofsarscov2mainproteasempro
AT jintengchuan designingofimproveddrugsforcovid19crystalstructureofsarscov2mainproteasempro